Search Result

Results for "

Sarcosine

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Amino Acid Derivatives (2) Biochemical Assay Reagents (7) Drug Derivative (2) Drug Intermediate (2) Endogenous Metabolite (10) GlyT (5) Isotope-Labeled Compounds (2) Liposome (1) Mitochondrial Metabolism (1) Reference Standards (1)
By Research Areas:	Cancer (7) Inflammation/Immunology (1) Metabolic Disease (7) Neurological Disease (1)
Click Chemistry:	Alkynes (1)

Inhibitors & Agonists

Peptides

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Click Chemistry

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-101037

*Sarcosine* 3 Publications Verification N-Methylglycine; Sarcosin	Endogenous Metabolite GlyT	Cancer
Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

HY-P2861

Sarcosine oxidase, Bacillus 1 Publications Verification SAO	Endogenous Metabolite	Others
Sarcosine oxidase, Bacillus (SAO) can catalyze the oxidative demethylation of sarcosine to generate glycine, H₂O₂, 5,10-CH₂-tetrahydrofolate, which are often used in biochemical reactions .

HY-P4198

Fmoc-N(Me)-Sar10 Fmoc-Sar10	Biochemical Assay Reagents	Others
Fmoc-N(Me)-Sar10 (Fmoc-Sar10) is an Fmoc-protected derivative of a methylated sarcosine decamer, which supports cell adhesion, proliferation, and maintenance of cell phenotype. Fmoc-N(Me)-Sar10 is primarily used in peptide synthesis to introduce enzymatically stable spacer sequences. By mimicking the extracellular matrix (ECM), Fmoc-N(Me)-Sar10 provides a 3D growth microenvironment for cells and is mainly used in tissue engineering and 3D cell culture, particularly suitable for in vitro culture studies of cells such as chondrocytes .

HY-N16040

DMG-pSar25	Liposome	Others
DMG-pSar25 is a double lipid-tailed polysarcosine lipid with 25 sarcosine moieties, serving as a PEG lipid substitute in lipid nanoparticle formulations for mRNA delivery. DMG-pSar25 supports mRNA delivery in lipid nanoparticle formulations .

HY-P2838

Creatininase, Microorganism 2 Publications Verification Creatinine amidohydrolase; CAH	Endogenous Metabolite	Metabolic Disease
Creatininase, Microorganism (Creatinine amidohydrolase; CAH), namely creatinine amidohydrolase, from Pseudomonas putida, is a homohexameric enzyme commonly used in biochemical research. Creatininase acts on carbon-nitrogen bonds other than peptide bonds, and can catalyze the hydrolysis of creatinine to creatine, which can then be metabolized by creatinase to urea and sarcosine .

HY-142035

N-Propargylglycine 1 Publications Verification	Mitochondrial Metabolism	Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
N-Propargylglycine is a brain-penetrant and orally active PRODH inhibitor. N-Propargylglycine covalently modifies enzyme-bound FAD and active site lysine, causing enzyme structural distortion, protein decay, and irreversible inhibition of proline and 4-hydroxyproline catabolism. N-Propargylglycine induces UPRmt, upregulates mitochondrial chaperones and YME1L1, enhances mitochondrial proteostasis, blocks astrocytic L-proline consumption, and abolishes L-proline’s ATP-maintaining and viability-protective effects. N-Propargylglycine stimulates neural processes, increases brain proline, hydroxyproline, and sarcosine levels, partially normalizes Huntington’s disease whole brain transcriptomes. N-Propargylglycine reduces hyperoxaluria, prevents calcium oxalate stone formation, reduces kidney tubular damage, and restores weight and survival in Grhpr knockout mice. N-Propargylglycine can be used for the research of breast cancer, neurodegenerative disorders, Huntington’s disease, and primary hyperoxaluria type 2 .

HY-101037S1

Sarcosine-d3 N-Methylglycine-d₃; Sarcosin-d₃	Isotope-Labeled Compounds Endogenous Metabolite GlyT	Cancer
Sarcosine-d₃ is the deuterium labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

HY-P2893

Creatinase, Actinobacteria Creatine amidohydrolase	Endogenous Metabolite	Others
Creatinase, Actinobacteria (Creatine amidohydrolase) is a hydrolase that catalyzes the hydrolysis of creatine into sarcosine and urea, and plays an important role in the enzymatic determination of creatinine concentration .

HY-P2893A

Creatinase (Recombinant) Creatine amidinohydrolase	Endogenous Metabolite	Metabolic Disease
Creatinase (Recombinant) is a hydrolase responsible for catalyzing the hydrolysis of creatine (HY-W010388) into sarcosine (HY-101037) and urea (HY-Y0271). Creatinase (Recombinant) can be used in conjunction with creatinine deiminase (HY-P2838) and sarcosine oxidase (HY-P2861) in an enzyme cascade reaction to measure creatinine (HY-B0504) levels in blood and urine. Creatinase (Recombinant) is the rate-limiting enzyme in this enzymatic cascade, and the enzymatic quantification of creatinine is an important method for evaluating kidney function .

HY-164166

Fmoc-Sar-Sar-Sar-OH	Biochemical Assay Reagents Drug Intermediate Amino Acid Derivatives	Others
Fmoc-Sar-Sar-Sar-OH is a small molecule polypeptide composed of sarcosine residues, in which the N-terminus of the peptide chain is protected by Fmoc. Fmoc-Sar-Sar-Sar-OH can be used for peptide synthesis or synthesis of agent-peptide ligand conjugates .

HY-101037R

Sarcosine (Standard) N-Methylglycine (Standard); Sarcosin (Standard)	Reference Standards Endogenous Metabolite GlyT	Cancer
Sarcosine (Standard) is the analytical standard of Sarcosine. This product is intended for research and analytical applications. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

HY-W1116287

N-Acetyl-Sar24	Drug Derivative Drug Intermediate	Others
N-Acetyl-Sar24 is an acetylated derivative of Sarcosine (HY-101037) .

HY-101037S

Sarcosine-15N N-Methylglycine-¹⁵N; Sarcosin-¹⁵N	Endogenous Metabolite GlyT	Cancer
Sarcosine- ¹⁵N is the ¹⁵N-labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

HY-Y1144

Sarcosine ethyl ester hydrochloride N-[(Ethoxycarbonyl)methyl]-N-methylamine hydrochloride; Sacrosine ethyl ester hydrochloride	Amino Acid Derivatives	Others
Sarcosine ethyl ester hydrochloride is a Glycine (HY-Y0966) derivative .

HY-W748519

Sarcosine-13C3 N-Methylglycine-¹³C₃; Sarcosin-¹³C₃	Isotope-Labeled Compounds GlyT Endogenous Metabolite	Cancer
Sarcosine- ¹³C₃ (N-Methylglycine- ¹³C₃; Sarcosin- ¹³C₃) is the ¹³C-labeled Sarcosine (HY-101037). Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

HY-W188178

N-Mitrososarcosine	Drug Derivative	Cancer
N-Nitrososarcosine is a nitrosation product of Sarcosine (HY-101037) and can be found in cured meat products. N-Nitrososarcosine (225 mg/kg) induces the formation of metastatic liver carcinomas in mice .

HY-172288

N-TETAMINE-pSar45	Biochemical Assay Reagents	Others
N-TETAMINE-pSar45 is a polysarcosine (pSar) derivative featuring an N-tetamine head group and a 45-mer polysarcosine tail. Sarcosine is an amino acid derivated that is being developed as an alternative to PEG for in vivo applications due to its biodegradability and highly reduced antigenicity. pSar-lipid derivatives such as this may be applied in the development of lipid nanoparticles.

HY-P2861A

Sarcosine Oxidase, E.coli	Biochemical Assay Reagents	Metabolic Disease
Sarcosine Oxidase, E.coli catalyzes the demethylation of sarcosine to glycine.

HY-E70955

Sarcosine Dehydrogenase, Pseudomonas sp.	Endogenous Metabolite	Metabolic Disease
Sarcosine Dehydrogenase, Pseudomonas sp. (EC 1.5.99.1) is a mitochondrial enzyme that catalyzes the chemical reaction N-demethylation of sarcosine to give glycine. Sarcosine dehydrogenase, Pseudomonas sp. (EC 1.5.99.1) is an oxidoreductase that acts on the CH-NH group of donor molecules and other acceptor molecules.

HY-172510

N-Hexadecyl-pSar25	Biochemical Assay Reagents	Others
N-Hexadecyl-pSar25 is a polysarcosine (pSar) derivative featuring a hexadecyl head group and a 25-mer polysarcosine tail. Sarcosine is an amino acid derivated that is being developed as an alternative to PEG for in vivo applications due to its biodegradability and highly reduced antigenicity. pSar-lipid derivatives such as this may be applied in the development of lipid nanoparticles.

HY-P2893C

Creatinase, Flavobacterium sp.	Biochemical Assay Reagents	Metabolic Disease
Creatinase, Flavobacterium sp. (EC 3.5.3.3) belongs to the hydrolase family and acts on carbon-nitrogen bonds other than peptide bonds, especially in linear amidine compounds. Creatinase, Flavobacterium sp. (EC 3.5.3.3) accelerates the conversion of creatine and water molecules into sarcosine and urea. Creatinase, Flavobacterium sp. (EC 3.5.3.3) functions as a homodimer.

HY-E71011

N-Carbamoylsarcosine Amidase, E.coli	Biochemical Assay Reagents	Metabolic Disease
N-Carbamoylsarcosine Amidase, E. coli, belongs to the hydrolase family. This family of enzymes acts on carbon-nitrogen bonds other than peptide bonds, particularly the carbon-nitrogen bonds in linear amides, and participates in the metabolism of arginine and proline. The two substrates of N-Carbamoylsarcosine Amidase, E. coli, are N-carbamoylsarcosine and H2O, while its three products are sarcosine, CO2, and NH3.ions to the healing immune response.

Cat. No.	Product Name	Target	Research Area

HY-P4198

Fmoc-N(Me)-Sar10 Fmoc-Sar10	Biochemical Assay Reagents	Others
Fmoc-N(Me)-Sar10 (Fmoc-Sar10) is an Fmoc-protected derivative of a methylated sarcosine decamer, which supports cell adhesion, proliferation, and maintenance of cell phenotype. Fmoc-N(Me)-Sar10 is primarily used in peptide synthesis to introduce enzymatically stable spacer sequences. By mimicking the extracellular matrix (ECM), Fmoc-N(Me)-Sar10 provides a 3D growth microenvironment for cells and is mainly used in tissue engineering and 3D cell culture, particularly suitable for in vitro culture studies of cells such as chondrocytes .

HY-164166

Fmoc-Sar-Sar-Sar-OH	Biochemical Assay Reagents Drug Intermediate Amino Acid Derivatives	Others
Fmoc-Sar-Sar-Sar-OH is a small molecule polypeptide composed of sarcosine residues, in which the N-terminus of the peptide chain is protected by Fmoc. Fmoc-Sar-Sar-Sar-OH can be used for peptide synthesis or synthesis of agent-peptide ligand conjugates .

HY-W1116287

N-Acetyl-Sar24	Drug Derivative Drug Intermediate	Others
N-Acetyl-Sar24 is an acetylated derivative of Sarcosine (HY-101037) .

HY-Y1144

Sarcosine ethyl ester hydrochloride N-[(Ethoxycarbonyl)methyl]-N-methylamine hydrochloride; Sacrosine ethyl ester hydrochloride	Amino Acid Derivatives	Others
Sarcosine ethyl ester hydrochloride is a Glycine (HY-Y0966) derivative .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-101037

*Sarcosine* 3 Publications Verification N-Methylglycine; Sarcosin	Human Gut Microbiota Metabolites Microorganisms Immune System Disorder Classification of Application Fields Disease markers Endocrine diseases Amino acids Endogenous metabolite Disease Research Fields Source Classification Cancer	Endogenous Metabolite GlyT
Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

HY-N16040

DMG-pSar25	Structural Classification Lipid	Liposome
DMG-pSar25 is a double lipid-tailed polysarcosine lipid with 25 sarcosine moieties, serving as a PEG lipid substitute in lipid nanoparticle formulations for mRNA delivery. DMG-pSar25 supports mRNA delivery in lipid nanoparticle formulations .

HY-101037R

Sarcosine (Standard) N-Methylglycine (Standard); Sarcosin (Standard)	Structural Classification Human Gut Microbiota Metabolites Microorganisms Immune System Disorder Disease markers Endocrine diseases Amino acids Endogenous metabolite Source Classification	Reference Standards Endogenous Metabolite GlyT
Sarcosine (Standard) is the analytical standard of Sarcosine. This product is intended for research and analytical applications. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

Tag:	His (1) Tag Free (1)
Source:	E. coli (2)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P702177

	*monomeric sarcosine* oxidase Protein, Bacillus sp.** soxA; Monomeric Sarcosine oxidase; MSOX	Others	E. coli
	Monomeric sarcosine oxidase protein is pivotal in cellular metabolism, catalyzing the oxidative demethylation of sarcosine. Its enzymatic activity facilitates the removal of a methyl group from sarcosine, contributing to metabolic transformations in various biochemical pathways. This process underscores the protein's significance in regulating cellular methyl group transfers, emphasizing its crucial role in maintaining metabolic homeostasis. monomeric sarcosine oxidase Protein, Bacillus sp. is the recombinant monomeric sarcosine oxidase protein, expressed by E. coli , with tag free.

HY-P702178

	*monomeric sarcosine* oxidase Protein, Bacillus sp. (His)** soxA; Monomeric Sarcosine oxidase; MSOX	Others	E. coli
	Monomeric sarcosine oxidase protein is pivotal in cellular metabolism, catalyzing the oxidative demethylation of sarcosine. Its enzymatic activity facilitates the removal of a methyl group from sarcosine, contributing to metabolic transformations in various biochemical pathways. This process underscores the protein's significance in regulating cellular methyl group transfers, emphasizing its crucial role in maintaining metabolic homeostasis. monomeric sarcosine oxidase Protein, Bacillus sp. (His) is the recombinant monomeric sarcosine oxidase protein, expressed by E. coli , with N-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-101037S1

Sarcosine-d3
Sarcosine-d₃ is the deuterium labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

Sarcosine-d3

Sarcosine-d₃ is the deuterium labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

HY-101037S

Sarcosine-15N
Sarcosine- ¹⁵N is the ¹⁵N-labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

Sarcosine-15N

Sarcosine- ¹⁵N is the ¹⁵N-labeled Sarcosine. Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

HY-W748519

Sarcosine-13C3
Sarcosine- ¹³C₃ (N-Methylglycine- ¹³C₃; Sarcosin- ¹³C₃) is the ¹³C-labeled Sarcosine (HY-101037). Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

Sarcosine-13C3

Sarcosine- ¹³C₃ (N-Methylglycine- ¹³C₃; Sarcosin- ¹³C₃) is the ¹³C-labeled Sarcosine (HY-101037). Sarcosine (N-Methylglycine), an endogenous amino acid, is a competitive glycine transporter type I (GlyT1) inhibitor and N-methyl-D-aspartate (NMDA) receptor co-agonist. Sarcosine increases the glycine concentration, resulting in an indirect potentiation of the NMDA receptor. Sarcosine is commonly used for the research of schizophrenia .

Cat. No.	Product Name		Classification